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Abstract
Wewant to demonstrate the feasibility of the concept of a cyber-physical system
(CPS) by showing good correlation of insulin resistance by HOMA-IR with changes
of state variables (SVs) such as R-ratio, Rw-ratio, calculated 24 h nonprotein respi-
ratory quotient, and fat-burning fraction from serial measurements of weight and
fat mass. We utilize principles of indirect calorimetry. We calculate SVs from
published data of an energy perturbation study. We perform correlation analysis
between changes of insulin resistance measured with HOMA-IR and selected SVs.
The result of this correlation analysis confirms a highly significant correlation
between HOMA-IR and the selected SVs. The implication of these results is that
CPS is a suitable concept to indirectly measure and predict the otherwise very-
difficult- or impossible-to-measure slow changes of SVs and capture them for the
first time noninvasively. Serial fat and weight measurements and energy calcula-
tions can help unmask changes of insulin resistance in response to user’s diet and
exercise habits, creating the necessary environment to measure metabolic flexibil-
ity. Further, CPS has the potential to estimate cardiorespiratory fitness by indirectly
estimating maximum oxygen uptake from measuring heart rate reserve, heart rate
variability, and pulse oximetry changes with exercise.
Keywords: energy metabolism, metabolic profile, insulin resistance,
metabolic monitoring, cardiometabolic health, self-management
1. Introduction
This book chapter introduces to practicing physicians the framework of our
cyber-physical system (CPS) for management and self-management of
cardiometabolic health. The hypothesis here is that cardiometabolic functions rele-
vant to cardiovascular disease (CVD) mortality including insulin resistance can be
tracked and predicted from measuring physical activity, heart rate, and pulse
oximetry by a smart watch and from serial weight and fat weight measurements
obtained from a bioimpedance fat scale. CPS serves the need for individualized
precision methods to gauge cardiometabolic health with metrics/trajectories and
predict slow changes of cardiometabolic health in health as well as in disease. There
is a need to provide this information as a feedback to patients and their care team to
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facilitate prevention and treatment of chronic noncommunicable disease, improve
rehabilitation after acute cardiovascular illness, and facilitate needed behavior
change for cardiometabolic risk reduction to improve cardiovascular as well as
all-cause mortality. Computer-generated feedback may provide a framework for
automation and self-improvement to meet daily goals of therapeutic efforts.
Based on our research in systems biology, a cyber-physical system (CPS) can be
construed for noninvasively tracking, drawing trajectories, and indirectly measur-
ing daily changes and predict the otherwise very-difficult- or impossible-to-mea-
sure slow changes of the daily state variables (SVs) of the metabolism and capture
them for the first time noninvasively in freely moving humans in their natural
environment outside of a metabolic laboratory setting.
Components of CPS are (A) a management software tool (MST); (B) a metabolic
health monitor (MHM) app; (C) software on MHM capturing biometric signals from
sensors of heart rate, physical activity, and pulse oximetry from a smart watch;
and (D) software on MHM capturing biometric signals related to body composition
and hydration status from Ori Diagnostic Instruments’ (ODI) patented apparatus for
impedance spectroscopy. MHM is running ODI’s proprietary self-adaptive individu-
alized stochastic mathematical model of the human energy metabolism (SAM-HEM)
[1–3] via cloud computing. Based on our published simulation studies, SAM-HEM is
a suitable concept to capture daily changes of the following SVs: weight; fat mass;
lean mass; protein mass; intracellular water mass; extracellular water mass; utilized
macronutrient intake and substrate oxidation of carbohydrate, fat, protein; and the
R-ratio (ratio of the daily lean mass change velocity divided by the daily fat mass
change velocity) which could be used as a surrogate marker for insulin resistance.
SAM-HEM is a self-learning algorithm with daily updates using the minimal variance
Kalman filter/predictor to arrive at the best metabolic model fitting to the available
measured data. The trajectories of SVs are displayed on MHM andMSTwith errors of
calculations allowing for analysis of past events, tracking current metabolic events
real time, predicting metabolic changes in the future, and supporting self-
management as well as guided therapies. We envision also that the same smart watch
can provide sufficient information to track cardiorespiratory fitness by estimated
maximum oxygen uptake. Our innovation is to merge the assessment of metabolic
fitness/flexibility measurements with the assessment of cardiorespiratory fitness and
realize CPS to improve cardiometabolic health.
The challenges ahead are the following: The prevalence of obesity and
type 2 diabetes (T2D) is ranked the highest in the USA and Mexico in the American
continent [4]. The proportion of the population with abnormal glucose tolerance is
52.4% for the USA (14.4% T2D, 38% prediabetes) [5] and 33.5% for Mexico (14.1%
T2D, 19.1% prediabetes) [6].
Central to our mission in primary care is to fight the burden of
noncommunicable chronic diseases including the most prominent one, cardiovas-
cular disease (CVD). CVD is substantially higher in individuals with unhealthy
lifestyle characteristics, including obesity, prediabetes, diabetes, insulin resistance,
metabolic syndrome, physical inactivity, poor diet, and cigarette smoking [7]. In
forging the battle against these problems, I see the following paramount problems:
1. There is a certain degree of fatigue toward “dieting,” “weight loss,” and
hearing the word “obese.” According to a recent survey [8], many sufferers of
obesity wanted to become “healthy” so they could be “fit” and “strong” and
expressed the wish for general health.
2. The problem with targeting weight loss only is that it does not distinguish
between the loss of adipose and lean tissues. Further, it intuitively contradicts
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the notion of the obesity paradox, i.e., increased BMI is associated with
increased survival and reduced mortality among patients with cardiovascular
risk [9]. A mortality study in adults showed that normal weight at the time of
incident diabetes had higher mortality than adults who are overweight or obese
[9, 10]. This apparent obesity paradox is best explained by insulin resistance
which is the primary underlying factor in cardiovascular disease. Fat mass
itself and insulin sensitivity (reciprocal of insulin resistance) may be the
decisive link between mortality and weight status [10]. Moreover, a more
recent study [11] confirms what most clinicians have felt for a long time that
obesity or excess fat mass with associated insulin resistance is directly
associated with shorter longevity and significantly increased risk of
cardiovascular morbidity and mortality [11]. Furthermore, when a surrogate
index of insulin resistance such as waist circumference is used to predict
mortality, an elevated waistline was strongly predictive of an increased
mortality rate among patients with cardiovascular disease [12], and it is an
independent risk factor for CVD mortality [13].
3.Clearly, there is a need for healthy lifestyle interventions using
self-management along with support team approach to prevent and treat
noncommunicable diseases linked to overweight and obesity [14] to achieve
cardiorespiratory fitness along with metabolic health with lowest possible
insulin resistance. Effective programs and technology tools together are
needed to support behavior change approaches toward healthy lifestyle.
Recently, behavior change strategies have emphasized the need for feedback
loops for self-directed behavior modification [15]. However, there is a paucity of
personalized, time-adjusted, dynamic interventions supporting feedback control
for health behavior interventions [16]. There is a needed tool to observe the slow
changes of cardiovascular fitness and metabolic health metrics closely as a
feedback of information for patient and primary care provider to facilitate self-
directed behavior change [3] as well as for guided therapy by the healthy
lifestyle team. The hurdles to develop such behavior change models with
dynamic feedback loops and corresponding supportive technology tools are (A)
the lack of gold standard measures for important behavior constructs, (B) tools
allowing for planning and executing dynamic changes of behavior, (C) a
dynamic behavior change model using self-directed behavioral change
strategies, and (D) outcome measures for optimization [3, 16].
Given the pandemic of overweight and obesity involving 1.9 billion people
worldwide according to the World Health Organization, new and fresh ideas and
approaches are needed. One of the goals of the current article is to introduce to
researchers and clinicians a widely applicable toolset which could unleash the
potential of the modern Digital Era and tackle the extraordinary burden of insulin
resistance, obesity, prediabetes, metabolic syndrome, and type 2 diabetes on
humanity. In this article, inspirations were taken from thoughts and works of giant
and prodigious scientists of the twentieth century, the unbelievably huge potential
of smartphone technologies, combined with the tremendous power of human net-
working through the Internet. With the current novel framework, we strive to use
the minimum set of assumptions about the process and measurement.
Eugene Wigner (1902–1995) stated that there is a “miracle of the appropriate-
ness of the language of mathematics for the formulation of the laws of physics” …
which may appear to us with “unreasonable efficiency.” The inspiration here is,
why not use mathematical tools for the formulation of the applicable laws to the
human energy metabolism such as the first and second laws of the thermodynamics
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when considering, for example, the fat balance, i.e., fat in minus fat out? Though
indirect calorimetry already makes reference to these laws, the indirect calorimetry
technology use is intricately connected to respiratory gas exchange measurements
which are difficult to do with the daily routine of life. However, mathematical
models can be created with input variables with easier realization in daily life such
as weight and fat weight measurement with bioimpedance fat scale. Further,
appropriately built mathematical models can provide indirect measurements of
difficult-to-measure variables of the human energy metabolism like fat versus car-
bohydrate oxidation rate or changes of insulin resistance [1–3] and provide a solu-
tion to gain a special quantified insight into the fat and the entire energy
metabolism. Currently, the computational model of the human energy metabolism
(CM-HEM) [17] and its improved version [18] is considered the most complete.
CM-HEM uses the three compartmental partitioning of the entire energy flow,
centered around the major macronutrient energy stores: glycogen G, fat F, and
protein P. Hall was able to test his model and found satisfactory agreement between
the model predictions and the measured group averaged data from the Minnesota
Study [17], as well as 50 other studies [18]. Although CM-HEM behaves appropri-
ately for different groups of subjects, it is presently unclear whether individual
subject responses can be predicted [19], and CM-HEM may be limited in its ability
to provide precise information on an individual basis [19]. Further, CM-HEM uses
food intake as an input rather than an output variable, and it would be particularly
interesting to determine utilized food intake from body composition changes [19].
CM-HEM is neither linear nor recursive nor individualized to a particular subject,
and therefore, it is not suited to performing recursive parameter identification of
the human energy metabolism, nor is it able to perform inverse calculation of
utilized energy intake. Further, insulin resistance is not considered in CM-HEM
when in fact insulin resistance plays a crucial role influencing fat and carbohydrate
oxidation rates and the entire dynamic of body composition change [1–3]. Obvi-
ously, individualized models are needed which can be tied to easily measurable
input variables such as weight and fat weight and provide insight into the fat and
nonfat energy balance and change of insulin resistance.
A second insightful guidance to our approach comes from John von Neumann
(1903–1957) for the fight against insulin resistance. During his time, he foresaw
already that “science, as well as technology, will in the near and in the farther future
increasingly turn to problems of structure, organization, information, and control.”
This raises the question, why not use Neumann’s self-organization and system
theory ideas to control and prevent insulin resistance and obesity? In this regard
using certain universal principles for energy calculation, such as the principle of
“least action/ stationary action,” for example, in Lagrangian and Hamiltonian
mechanics, can be instrumental in setting up suitable control equations or func-
tionals, such as the Hamilton-Jacobi-Bellman equation in control theory for
dynamic optimized control [20]. This Hamilton-Jacobi-Bellman equation can allow
for dynamic optimization of the energy system to achieve the desired state in the
shortest possible time with minimized efforts.
The third inspirational insight comes from Rudolf E. Kálmán (1930–2016) and
his invention of the “Kalman filter.” This is briefly a statistical tool with tremen-
dously widely used successful applications to control a vast array of consumer,
health, commercial, and defense products. According to Grewal [21], the Kalman
Filter is possibly the greatest discovery in the twentieth century and made the moon
landing among others possible. This raises the question, why not use the Kalman
filter to estimate and predict fat mass change? A potential application of Kalman’s
minimum variance estimator and predictor could be twofold: (1) Updating the a
priori estimation equations for the measurement variables (weight, fat weight) with
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a posteriori results and (2) providing a posteriori estimation for the process vari-
ables such as lean mass L, glycogen mass G, fat mass F, protein P, intracellular water
mass ICW, and extracellular water mass ECW. This will realize a dynamic state-
space modeling connecting the measured variables with the process variables, never
losing the measured reality and keeping full statistical knowledge about confidence
intervals and other statistical properties of results. The beauty of the Kalman esti-
mators is that they operate also as a predictor when no updated measurements are
provided.
Central to the development of the noninvasive metrics for the human energy
metabolism is to have a novel metric for insulin resistance from energy flow
point of view through the body. Insulin resistance is related to ectopic fat
accumulation and reduced capacity of fat oxidation and inflexibility in regulating
fat oxidation combined with the increased propensity of glucose oxidation and
glucose-induced suppression of fat oxidation [22]. Experimental weight perturba-
tion showed concordant changes of the glucose vs. fat oxidation fraction in
skeletal muscle [23]. The correlation between BMI/weight/body composition and
insulin resistance measured, for example, with Homeostatic Model Assessment of
Insulin Resistance (HOMA-IR), is well documented in the medical literature
[24, 25]. It is increasingly recognized also that there is a dynamic correlation
between changes of weight, fat weight, and insulin sensitivity/resistance changes.
Building on the above observations and reviewing energy perturbation studies
from the international literature, we observed also a high level of correlation
between weight, fat weight, and HOMA-IR [26]. We found also that our newly
defined R-ratio and Rw-ratio showed highly significant correlation with
HOMA-IR, and we proposed these measures as metrics for insulin resistance [2, 3, 26].
We recognized that monitoring R-ratio and Rw-ratio may give an important tool for
monitoring changes of insulin resistance; we developed CPS for this purpose.We have
provided the derivation of our formulas used in CPS in the Appendix. The lists of
measured and derived variables in CPS are listed in the glossary.
The essential input parameters, weightWk and fat weight Fk, are captured by
the software on MHM from a “bathroom scale” performing measurements of body
composition (weight, fat weight) and hydration status (intracellular and extracel-
lular water mass) developed by Ori Diagnostic Instruments (ODI), which is a
patented apparatus for impedance spectroscopy [27, 28]. Without calorie counting
and just using the required input ∆Wk, ∆Fk, and EBk, the fat and nonfat energy
balance can be estimated along with the weight-related alpha α^wk, the energy
density parameter for weight change ^ϱWk, the weight-related Rw-ratio Rwk, the
lean mass-related alpha α^k, the energy density parameter for lean mass change ϱ^Lk,
the lean mass-related R-ratio Rk, the nonprotein respiratory quotient Rnpk, and the
fat-burning fraction χk as in Eqs. (1)–(19).
With additional measurement of physical activity (PAE) energy expenditure via
smart watch sensors and using the measured or calculated value of the basal meta-
bolic rate BMRk (by either using Harris-Benedict formula or by actual measurement
of BMRk with indirect calorimetry), the total energy expenditure can be obtained as
in Eq. (20).
If steady-state equilibrium in the metabolism can be assumed and the total
energy expenditure is known, then it is possible to calculate food fraction φk, total
metabolized energy intakeMEIk, fat intake FIk, and fat oxidation FOk in addition to
α^wk, α^k, ^ϱWk, ϱ^Lk, Rk, Rwk, Rnpk, and χk.
If equilibrium state is uncertain, then we would recommend additional
macronutrient calorie counting on designated calibration days (maybe every 2weeks).
This could improve accuracy andwould allow deeper insight into the dynamics of SVs
of the metabolism.
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One of the goals of this chapter is to demonstrate the feasibility of the concept of
CPS for its main function which is to predict changes of insulin resistance and fat
oxidation from serial measurements of weight and fat mass. Unfortunately, there is
a paucity of published data with longitudinal observations and serial measurements
of the measurable components of the energy metabolism including measuring
markers of insulin resistance. A complete data set to study the insulin resistance and
weight-fat weight relationship would require the following data: serial measure-
ments of macronutrient energy intake (EI), total energy expenditure (TEE) and
serial fat mass (F), and lean body mass (L) or weight (W) measurements. Very few
trial data are published only with serial measurements of markers of insulin sensi-
tivity or resistance. Nevertheless, we were able to identify a study suitable for our
aim, which is to demonstrate the feasibility of our concept of CPS to track and
predict SVs and markers of insulin resistance. Here we use published data from the
study entitled “Effects of brief perturbation in energy balance on indices of glucose
homeostasis in healthy lean men (EBPE) [29].”
2. Method
For all calculations I used MATLAB. To demonstrate the main functions of our
CPS, we use here the published data of EBPE [29]. In this study 10 healthy men
participated in two cycles of controlled 7-day periods of caloric restriction (CR)
and refeeding (RF) in protocol A and overfeeding (OF) and caloric restriction (CR)
in protocol B at 60% energy requirement. Insulin resistance was assessed by
HOMA-IR on the basis of measured serum insulin and glucose levels in the study
participants. The mandatory input data to CPS is weight, fat weight, and daily
energy balance values EBk. The daily weights were directly scanned in from the
published graphs [29]. The fat weight data points were available only at baseline
and at the end of CR, RF, and OF cycles. I used MATLAB’s Piecewise Cubic
Hermite Interpolating Polynomial to connect these fat data points in order to have
daily fat mass estimates (see Figure 1a and b). I calculated the energy balance EBk
from the difference of the metabolically utilized energy intake minus total energy
expenditure.
I estimated weight-related alpha α^wk, energy density parameter for weight ^ϱWk,
Rw-ratio Rwk, and fat-burning fraction χk from ∆Wk, ∆Fk, and EBk utilizing the
methods described in Eqs. (1)–(19).
Figure 1.
(a) Daily weight and fat weight in protocol A. (b) Daily weight and fat weight in protocol B.
6
Type 2 Diabetes - From Pathophysiology to Modern Management
For calculation of correlations between HOMA-IR and weight, fat weight, R-
ratio, Rw-ratio, fat-burning fraction χk, and nonprotein respiratory quotient Rnpk, I
used MATLAB’s corrcoef function.
For demonstration purposes, I plugged the mandatory input variables ∆Wk,
∆Fk, and EBk as well as the known ingested macronutrient calories CIk, FIk, and PIk
into SAM-HEM algorithm with Kalman filter [1–3]. As a measure of goodness of fit
of the metabolic model SAM-HEM, I calculated the predicted mean value and
standard deviation of the modeling error, i.e., model-predicted value minus the
known trajectory of weight, fat weight, and lean mass.
3. Results
The input weight and fat weight data are shown in Figure 1a for Protocol A and
in Figure 1b for Protocol B. The measured data points for fat mass are connected
with MATLAB’s Piecewise Cubic Hermite Interpolating Polynomial. The results of
Rw-ratio Rwk and fat-burning fractionation χk for Protocols A and B are in
Figure 2a and b, respectively. The measured data points for HOMA-IR are
connected with MATLAB’s Piecewise Cubic Hermite Interpolating Polynomial.
Figure 2.
(a) Daily changes of Rw-ratio, χk, and Homa-IR in protocol A. (b) Daily changes of Rw-ratio, χk, and Homa-
IR in protocol B.
Figure 3.
(a) Daily changes of Rnp and Homa-IR in protocol A. (b) Daily changes of Rnp and Homa-IR in protocol B.
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In Figure 3a and b, the changes of the nonprotein respiratory quotient can be
seen for Protocol A and for Protocol B. Figure 4a for Protocol A and Figure 4b
for Protocol B show the results of utilized macronutrient intakes carbohydrate CI
and fat FI, as well the macronutrient oxidations for carbohydrate CarbOx and
fat FatOx.
The correlation coefficients between HOMA-IR andWk, Fk, Rk, Rwk, Rnpk,
and χk along with their P value are shown in Table 1.
The results of goodness of fit of the SAM-HEM metabolic model to the known
trajectory of weight, fat weight, and lean mass are shown in Table 2.
Figure 4.
(a) Daily metabolized carbohydrate and fat intake and oxidation in protocol A. (b) Daily metabolized
carbohydrate and fat intake and oxidation in protocol B.
Protocol A Protocol B
HOMA-IR P value HOMA-IR P value
Wk 0.828219114701 0.000003557891 0.6464400352912 0.00154355168
Fk 0.873415795383 0.000000235522 0.9999138255551 0.00000000000
Rk 0.77770999896 0.000033325699 0.971975709210 0.00000000000
Rwk 0.92129422123 0.000000003126 0.967645037740 0.00000000000
Rnpk 0.935321042397 0.000000000000 0.9529177800117 0.00000000000
χk 0.9354436104 0.000000000000 0.952802142972 0.00000000000
Table 1.
Correlation coefficients between HOMA-IR and Wk, Fk, Rk, Rwk, Rnpk, and χk:
Protocol A Protocol B
Mean deviation in
grams
Standard
deviation
Mean deviation in
grams
Standard
deviation
Wk 220.1045 893.8795 289.2232 512.9418
Fk 11.8265 122.9743 13.3447 94.0426
Lk 21.8630 90.8594 35.0486 40.6444
Table 2.
Goodness of fit of the SAM-HEM metabolic model to Wk, Fk, and Lk data.
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4. Discussion
Insulin resistance is a pathogenic factor for type 2 diabetes. Insulin resistance has
a deleterious impact on glucose and lipid metabolism, blood pressure, coagulation
abnormality, inflammation, oxidative stress, and endothelial dysfunction. Popula-
tion studies suggest that insulin resistance is an important target to reduce CVD risk
[30]. A significant proportion of apparently healthy subjects are insulin resistant.
About 30–40% of subjects are afflicted with insulin resistance in affluent countries,
and the total number is over 1 billion worldwide [30]. HOMA-IR-estimated insulin
resistance is associated with subsequent symptomatic CVD in the general popula-
tion independent of all classic and several nontraditional risk factors [30]. The main
result of EPBE [29] is that it clearly demonstrates the profound effect of energy
perturbation on changes of insulin resistance. Insulin resistance remained slightly
impaired at the end of Protocol A (CR followed by RF) as opposed to the end of
Protocol B (OF followed by CR) where the insulin resistance created by OF was
normalized by CR. As it is discussed by the authors of [29], the benefit of calorie
restriction in terms of improvement of insulin sensitivity is firmly established in the
medical literature in various disorders like binge eating with bulimia, weight
cycling, obesity, and type II diabetes. In the EPBE study, euglycemic clamp mea-
surements were performed parallel to the HOMA-IR. Observing these in parallel, an
overarching picture emerges that the sugar and insulin dynamics are strongly
connected to quantifiable dynamics of body composition and the fat metabolism as
well as the carbohydrate- vs. fat-burning energy utilization.
Our feasibility demonstration for the main features of CPS is focused on
assessing changes of insulin resistance. Using trial data from EBPE [29], we corre-
lated HOMA-IR as a surrogate marker for insulin resistance with our surrogate
markers such as R-ratio, Rw-ratio, 24 h nonprotein respiratory quotient, and
fat-burning fraction. We found high correlation across the examined metabolic
variablesWk, Fk, Rk, Rwk, Rnpk, and χk with HOMA-IR along with highly signif-
icant P value for each examined variable.
The implication is that these results show strong evidence for the feasibility for
our concept to a have a noninvasive long-term monitoring tool for insulin resistance
for users in their natural environment. DisplayingWk, Fk, Rk, Rwk, Rnpk, and χk
on MHM and MST via our CPS can provide the needed tool to users and their
providers to observe and use adaptive control strategies to improve the otherwise
undetectable and invisible phenomena caused by insulin resistance and reach
metabolic health.
A new method for metabolic research has been introduced here to extend the
principles of indirect calorimetry to a broader application which considers serial
measurements of changes of body composition and hydration status with no gas
exchange measurements and is still able to estimate 24 h nonprotein respiratory
quotient. For this purpose, a Lagrangian functional L was set up to establish the
quantitative relationships between changes of fat mass, weight, and energy balance.
Without calorie counting and just using the required input weight change ∆Wk, fat
mass change ∆Fk, and energy balance EBk, the fat and nonfat energy balance can be
estimated along with important semi-stable energy parameters of the metabolism
including the weight-related alpha α^wk, the energy density parameter for weight
change ^ϱWk, the weight-related Rw-ratio Rwk, the lean mass-related alpha α^k, the
energy density parameter for lean mass change ϱ^Lk, the lean mass-related R-ratio
Rk, the nonprotein respiratory quotient Rnpk, and the fat-burning fraction χk.
Finding proof for the quantitative relationship between insulin resistance and
Rwk, Rk, Rnpk, and χk was difficult due to lack of previous studies [24] with the
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needed measurements and due to non-availability of individual data of participants
of potentially qualified metabolic studies. Thompson and Slezak [25] showed first
that weight and fat loss are correlated well with markers of insulin resistance/
sensitivity. Kelley et al. [22] was able to show that in vivo insulin sensitivity was
related to a higher in vitro capacity for fat oxidation of skeletal muscle samples. The
same author found also that the strongest predictor of improved insulin sensitivity
was associated with enhanced fasting rates of fat oxidation. In this context “meta-
bolic flexibility” in the skeletal muscles is discussed in the literature [24, 31]. One
definition of metabolic flexibility is the ability to switch from fat to carbohydrate
oxidation during insulin-stimulated glucose disposal. Another definition of meta-
bolic flexibility is the capacity for the organism to adept fuel oxidation to fuel
availability [31]. The opposite of metabolic flexibility is metabolic inflexibility
which is an important feature of insulin resistance. In the state of insulin resistance,
the fuel switching is impaired, and there is an impaired capacity to upregulate
muscle lipid oxidation. Metabolic inflexibility and state of insulin resistance mani-
fest as decreased fasting rates of fat oxidation and the lack of further suppression of
fat oxidation during heightened level of insulin action postprandially [32]. A defin-
ing characteristic of metabolic inflexibility is when after a fat-rich diet, an impaired
drop of overnight fasting RQ (impaired fat oxidation) can be observed. Further,
insulin-resistant subjects manifest less lipid oxidation during fasting condition and
greater lipid oxidation during insulin-stimulated conditions relative to non-insulin-
resistant subjects. The failure to augment lipid oxidation during fasting conditions
likely is a key mechanism leading to lipid accumulation within skeletal muscle [32].
Supporting evidence for impaired lipolysis, diminished fat oxidation, and metabolic
inflexibility was confirmed recently in obese girls with polycystic ovary syndrome
and increased insulin resistance [33].
The main likely mechanism of metabolic inflexibility is that the impaired capac-
ity to upregulate muscle lipid oxidation in the face of high lipid supply may lead to
increased muscle fat accumulation and insulin resistance [31]. Many studies have
shown when people are in energy balance, the 24 h food fraction φk, fat-burning
fraction χk, and nonprotein respiratory quotient Rnpk match each other [31]. With
the current technology, metabolic flexibility can be studied in a metabolic chamber
by measuring RQ. The testing modalities include overnight sleep study with RQ
measurement or measuring RQ in response to high-carbohydrate diet or in response
to high-fat diet [31]. The overnight study can show that the subject with metabolic
inflexibility would burn less fat during fasting state than the individual with normal
metabolism. At least 2 days of waiting is needed for seeing a clear difference in
response between flexible and inflexible individuals when dietary changes are
performed because adaptive mechanisms of the body prevail initially. The person
with metabolic inflexibility would burn less sugar compared with a person with
metabolic flexibility in response to high-carbohydrate diet. Conversely, the fat
burning is better in the normal metabolism than the impaired flexibility in response
to the high-fat diet. After 6–7 days, an equilibrium sets in again, and the final RQs
become indistinguishable between sufferer of inflexibility and healthy, and the 24 h
food fraction φk and fat-burning fraction χk settle close to the same value [31]. In
summary, it is tempting to speculate that a CPS equipped with the capability to
monitor nonprotein respiratory quotient Rnpk could detect flexibility vs. inflexibil-
ity in response to dietary challenges of the user in his or her natural environment.
It is important to point out that the energy perturbation study EPBE /34/ was
done in healthy men with no confounding metabolic abnormalities. Nevertheless,
the correlation analysis reveals the profound connection between insulin resistance
change (as measured by HOMA-IR) and energy metabolism with manifestations of
10
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substrate utilization and fat-burning capability. This becomes significant when we
want to measure metabolic flexibility and create a metric for metabolic health in
general. As insulin resistance (and HOMA-IR) is connected to mortality, so is
metabolic inflexibility which could be now measured outside of a metabolic labora-
tory. In earlier publications of ours, we found evidence for close correlation already
between HOMA-IR and R-ratio in a wide variety of clinical conditions including
obesity, postmenopausal state, metabolic syndrome, and prediabetes /2, 3, 24/. Data
from EPBE /34/ prove now that the connection between insulin resistance and R-
ratio or metabolic flexibility/inflexibility exists across human physiology and path-
ophysiology in health or disease. Actually, EPBE /34/ helped defining the quantifi-
able meaning of “metabolic health,” and we have now practically usable metrics for
it explaining also the title of this chapter.
It is important to consider why visceral obesity and the associated increased
waist circumference are a good predictor for CVD mortality [33]. The visceral fat
leads to high concentration of fatty acids which contributes to impaired liver
metabolism and fatty liver. The visceral adipose tissue has been shown to be loaded
with macrophages which contribute to the pro-inflammatory profile of visceral
obesity which would drive endothelial dysfunction and contributes to mortality.
The visceral obesity-induced lipo-toxicity eventually leads to ectopic fat depositions
not just in the liver but also the heart, kidney, and also skeletal muscle [34]. For
management of visceral obesity, prediabetes, metabolic syndrome, and type 2 dia-
betes, it is important to know that physically very active persons afflicted with these
conditions experience 50% reduction of CVD risk burden [33]. Further, physical
activity induces a selective mobilization of visceral adipose tissue and ectopic fat
even in the absence of weight loss. Consequently, our “leap ahead” innovation to
unify metabolic function assessment with cardiopulmonary fitness assessment may
provide an important tool to fight for less insulin resistance and higher cardiorespi-
ratory fitness. CPS has the promise to become a comprehensive cardiometabolic
function assessment tool in freely moving individuals requiring only wearing a
smart watch and using a specialized stand-up scale (high accuracy bioimpedance
analyzer) for serial measurement of fat mass and weight.
Increased insulin resistance states in obesity, prediabetes, metabolic syndrome,
and type 2 diabetes represent a high-risk state for CVD. Restoration of impaired
insulin resistance and its manifestation of impaired glucose tolerance can signifi-
cantly reduce the risk of future diabetes in prediabetics and decrease the estimated
CVD risk [34]. The diabetes prevention program (DPP) [35, 36] showed a clear
reduction in diabetes incidence in participants assigned to the lifestyle interventions
or metformin. Actually, lifestyle intervention was about twice as effective as met-
formin for prevention of diabetes and was the only intervention associated with
regression to normal glucose regulation. Seeing the overwhelming evidence of
importance of lifestyle change, we propose to utilize a CPS-like approach as
outlined in introduction to help this process. CPS can be used to observe SVs such as
weight, lean body mass, fat mass, R-ratio, Rw-ratio, calculated 24 h nonprotein
respiratory quotient, and fat-burning fraction from serial measurements of weight,
fat mass, and daily energy balance estimates EBk. EBk can be obtained either as per
Eq. (5) with no calorie counting requirement or for enhanced accuracy with calorie
counting and measurements of the physical activity energy expenditure and fol-
lowing Eq. (20). As a workable answer to behavioral changes mentioned in the
introduction, we propose using SVs for “(A) gold standard measure” for metabolic
functioning and as “(D) outcome measures for optimization” as a foreseen requisite
to make breakthroughs in the fight against obesity and insulin resistance [3, 15, 16].
The predictive power of SAM-HEM can draw trajectories of SVs and allow for trend
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analysis and prediction and serve as “(B) …tools allowing for planning and execut-
ing dynamic changes of behavior,” as desired by behavior scientists [15, 16]. The
desire for a (C) dynamic behavior change model development using self-directed
behavioral change strategies can arrive with further development of CPS using
control equations like the Hamilton-Jacobi-Bellman equation for dynamic opti-
mized control [20] and with further technologies of artificial intelligence.
The main contribution of this chapter to medicine and life science is that it lays
out a framework using CPS to observe and monitor long-term SVs of the metabo-
lism including markers of insulin resistance. The CPS approach may point to new
and promising directions to find workable solutions to challenges of unhealthy
metabolic conditions such as insulin resistance, obesity, prediabetes, metabolic
syndrome, and type 2 diabetes.
5. Conclusion
We provided important supportive evidence for feasibility for our concept of
CPS for indirectly measuring and predicting the otherwise very-difficult- or
impossible-to-measure slow changes of SVs and capture them for the first time
noninvasively in freely moving humans in their natural environment outside of a
metabolic laboratory setting. Serial fat and weight measurements and energy calcu-
lations can help unmask changes of insulin resistance in response to user’s diet and
exercise habits, providing tools to measure metabolic flexibility which can be used
as a surrogate marker for metabolic health. Further, CPS has the potential to esti-
mate cardiorespiratory fitness by indirectly estimating maximum oxygen uptake
from measuring heart rate reserve, heart rate variability, and pulse oximetry
changes with exercise. CPS is a tool to observe the two major risk factors of CVD at
the same time: metabolic health and cardiorespiratory fitness, and therefore the
new term cardiometabolic health is justifiable and introduced here to emphasize the
two interlinked physiological functions impacting mortality significantly. CPS can
enable managed and self-improvement of cardiometabolic health. CPS armed with
further technologies of control engineering and artificial intelligence can unleash
the potential of digital health to help manage conditions essential to primary care
and to the public at large.
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Glossary
Measured variables
Fk fat weight
∆Fk fat mass change in 24 h
Wk weight
∆Wk body weight change in 24 h
EBk daily energy balance
Derived or estimated variables
BMRk basal metabolic rate
CIk carbohydrate calorie intake
COk oxidized carbohydrate calories
ECWk extracellular water mass
FIk fat intake
FOk oxidized fat calories
ICWk intracellular water mass
Lk lean mass
∆Lk lean mass change in 24 h
MEIk metabolically utilized energy intake
PAEk physical activity energy expenditure via smart
watch sensors
TEEk total energy expenditure
Rk R-ratio
Rwk Rw-ratio
Rnpk nonprotein respiratory quotient
αk first-order term coefficient of the lean body—fat
logarithmic relationship Tylor series expansion
α^k estimation of αk
αwk first-order term coefficient of the weight—fat
logarithmic relationship Tylor series expansion
α^wk estimation of αwk
ϱF ≈ 9:4 Kcal/g energy density for fat
ϱL ≈ 1:8 Kcal/g the energy density for lean mass
ϱ^Lk estimation of ϱL
ϱWk energy density for weight
^ϱWk estimation of ϱWk
φk fat intake fraction
χk fat-burning fraction
A. Appendix
The following mathematical descriptions use elementary mathematics and a
minimum set of assumptions, similar to the landmark article of [37]. These equa-
tions could be regarded as an extension of the work of [37], with my main points
being that the fat-burning fraction can be calculated from serial fat and weight
changes, producing the same result as 24 h indirect calorimetry. Importantly, the
equations allow the clinician to determine the nonprotein respiratory quotient with
serial weight and fat weight measurement, avoiding the necessity for gas exchange
analysis. An important advantage of this mathematical method is that it can be used
anywhere outside of a metabolic laboratory.
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The R-ratio for modeling of the insulin resistance is defined in our analysis as the
ratio of lean body mass change velocity ∆Lk (lean mass change in 24 h) and fat mass
change velocity ∆Fk (fat mass change in 24 h) of day k as in Eq. (1).
Rk ¼
∆Lk
∆Fk
: (1)
Likewise, Rw-ratio can be defined as the ratio of weight change velocity ∆Wk
(body weight change in 24 h) and fat mass change velocity ∆Fk (fat mass change in
24 h) of day k as in Eq. (2).
Rwk ¼
∆Wk
∆Fk
: (2)
We proposed the Rw-ratio for modeling of the insulin resistance as it is easier to
measure change of weight than lean mass [26].
The total energy balance for the day k can be expressed as in Eq. (3):
ϱWk  ∆Wk þ ϱF  ∆Fk ¼ MEIk  TEEk: (3)
The same energy balance as in (3) can be expressed also using Rw-ratio or Rwk as
in Eq. (4):
ϱWk  Rwk þ ϱF
 
 ∆Fk ¼ MEIk  TEEk ¼ EBk: (4)
According to (3) and (4), the total energy balance (metabolically utilized energy
intakeMEIk minus total energy expenditure TEEk) is connected to changes of
weight ∆Wk and body fat mass change ∆Fk at the end of day k where the energy
distribution is governed by the energy density parameter for weight ϱWk and fat ϱF.
In the case of positive energy balance, ∆Lk, ∆Wk, and ∆Fk will have a positive sign,
otherwise negative. ϱF is the daily energy density of the fat mass change which is
estimated to be ϱF ≈ 9:4 Kcal/g. Rwk and ϱWk need to be estimated as direct mea-
surement is not possible. The main idea and proposition here are to estimate Rwk
from serial weight and fat weight measurement. ϱWk is estimated here from serial
measurement of weight and energy balance EBk. Accordingly, the input to our
models is going to be known measured values of daily weightWk and fat weight Fk.
The daily energy balance EBk is indirectly measured or calculated. If no calorie
counting and total energy expenditure measurements are done, then the option
exists to use (5):
EBk ≈ ϱL  Rk þ ϱFð Þ  ∆Fk: (5)
Here the energy density value of lean mass change ϱL is used, which is assumed
to be around ϱL ≈ 1:8 Kcal/g and is a semi-stable value [19]. Now the estimation of
Rk and Rwk is needed. Here we exploit the observation that there is a logarithmic
relationship between lean mass and fat mass according to Forbes [38]:
Lk ¼ αk  ln Fkð Þ: (6)
The same assumption can be used for weight and fat weight interrelationship:
Wk ¼ αwk  ln Fkð Þ: (7)
Now the daily lean mass change ∆Lk can be connected to the daily fat change
∆Fk using the first-order term coefficient in the Taylor series expansion. It is
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noteworthy that this calculation avoids the division by zero for cases when there is
no change of fat mass.
Rk ¼
∆Lk
∆Fk
≈
αk
Fk
: (8)
Here alpha αk is the first-order term coefficient in the Taylor series expansion
of the lean body-fat logarithmic functional relationship. For the value of
α ¼ 10:4 is used [38] if mass is measured in kilograms. Though intuitively it is felt
that this may not be the case for everybody every time, the stability assumption
for α over prolonged time is made by multiple authors [19, 38, 39]. Obviously,
finding the individual applicable value of αk is desired [19].
Now, the daily weight change ∆Wk can be connected to the daily fat change
∆Fk using the first-order term coefficient in the Taylor series expansion similar
to Eq. (8).
Rwk ¼
∆Wk
∆Fk
≈
αwk
Fk
: (9)
Obviously, finding the individual applicable value of the semi-stable daily lean
mass change-related alpha αk, weight-related alpha αwk, and ϱWk is needed. For this
purpose we want to take advantage of the principle of “least action” or “stationary
action,”which is assumed to hold true at steady state of an energy system. The same
principle is widely used in Lagrangian or Hamiltonian mechanical systems. We
want to extend this variational principle to the thermodynamic system of the
human energy metabolism. Briefly stated, the time integral of a thermodynamic
energy functional (Lagrangian functional) of the observed energy system under
stationary assumption will assume a minimum value. The justification for our
approach is that the first and second laws of thermodynamics (Hess’s law) are fully
applicable for indirect calorimetry as well as thermic energy calculations [37, 40].
The use of the principle of “least action/stationary action” will predict that the
energy metabolism works with the minimum consumption of fuel and would not
waste energy unnecessarily. Here we introduce our thermodynamic Lagrangian
functional where the time integral is replaced by summation of energies for each
day from day k ¼ 1 to day k ¼ N:
L ¼ ∑
k¼N
k¼0
ϱWk  Rwk þ ϱF
 
 ∆Fk
 2
þ λαwk  ∆Wk  αwk  lnFk  lnFk1ð Þ½ 
þ λϱWk  EBk  ϱWk  ∆Wk  ϱF  ∆Fk
 
:
(10)
The minimum solution of L is sought for very slow changing semi-stable αwk
and ϱWk for known ∆Fk, ∆Wk, and EBk. This solution could be obtained with
numerical methods to minimize the Lagrangian functional L. The Lagrange multi-
pliers λαwk and λϱWk are non-zero variables and are part of the minimization
procedure, and they multiply the constraints for conservation of mass and energy,
respectively. Metabolic studies suggest that a new steady state of equilibrium ensues
in 5–6 days [31] after a change of input variables occurs and equilibrium is
reached. The parameters αwk and ϱWk can be considered stable. The Lagrangian
functional Lmay also contain the parameter αk in a similar fashion to αwk if needed.
Instead of using head-on numerical minimization methods to find the semi-stable
parameters αwk and ϱWk, I prefer using the recursive least square method (RLS) of
the general form yk ¼ z^  xk where the time-dependent variables yk and xk are
known and estimate for parameter z^ is sought. RLS has the advantage that the
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estimate of z^k1 at time k 1 can be updated at the arrival of the new measured
variables yk and xk. This method allows us to estimate α^wk when ∆Wk, ∆Fk, and Fk
are available. Similarly, ^ϱWk can be estimated when a new set of ∆Wk, ∆Fk, and EBk
are available.
Once all parameters of the energy balance Eq. (4) are known, the nonfat
energy balance and fat energy balance can be calculated as in Eqs. (11) and (12),
respectively:
ϱWk  ∆Wk ¼ 1 φkð Þ MEIk  1 χkð Þ  TEEk, (11)
ϱF  ∆Fk ¼ φk MEIk  χk  TEEk: (12)
Here φk designates fat intake fraction as defined in Eq. (13), and χk denotes the
fat-burning fraction as in Eq. (14).
φk ¼
FIk
MEIk
, (13)
and
χk ¼
FOk
TEEk
: (14)
In Eq. (13), FIk represents fat intake, and in Eq. (14), FOk stands for oxidized fat
calories of day k:
We made an important observation in [2, 3, 26] that the R-ratio Rk strongly and
negatively correlates with HOMA-IR. Building on this observation and using Rw-
ratio Rwk, we introduce here a possible modeling of the connection between insulin
resistance and substrate fractionation. At assumed steady state, the fat-burning
fraction χk approximates food fraction φk according to [31], and they become quasi
equal. Under this condition the nonfat and fat energy balance can be written in a
simplified form as in Eqs. (15) and (16):
ϱWk  ∆Wk ¼
ϱF
ϱWk  Rwk þ ϱF
 MEIk  TEEkð Þ, (15)
ϱF  ∆Fk ¼
ϱWk  Rwk
ϱWk  Rwk þ ϱF
 MEIk  TEEkð Þ: (16)
Accordingly, the carbohydrate burning fraction 1 χk and the fat-burning frac-
tion χk can be written as in Eqs. (17) and (18):
1 χk ¼
ϱF
ϱWk  Rwk þ ϱF
¼
COk
COk þ FOk
, (17)
χk ¼
ϱWk  Rwk
ϱWk  Rwk þ ϱF
¼
FOk
COk þ FOk
: (18)
Important properties of Eqs. (15) and (16) are that they add up to the total
energy balance equation as in Eq. (3). It can be seen in this pair of equations that
with decreasing insulin resistance, i.e., decreasing HOMA-IR and concomitantly
increasing Rw-ratio Rwk, the fat-burning fraction χk increases, and the carbohy-
drate burning fraction 1 χk would decrease. Similarly, with increasing insulin
resistance, i.e., increasing HOMA-IR and concomitantly decreasing Rw-ratio Rwk,
the fat-burning fraction χk decreases, and carbohydrate burning fraction 1 χk
would increase as demonstrated in Figure 2a and b.
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Further, according to Elia and Livesey [37] during nonprotein energy produc-
tion, the nonprotein respiratory quotient Rnpk can be calculated from the fat-
burning fraction χk using stoichiometry under the assumption that mainly
dioleylpalmityltriglyceride and glucose are used as fuels for oxidation as in Eq. (19)
adopted from Elia [37].
Rnpk ¼
a χk  aþ χk  b  c
a χk  aþ χk  b
: (19)
The constant values in [37] are a ¼ 19:502, b ¼ 21:120, and c ¼ 0:7097.
All calculations from Eqs. (1)–(19) use the same assumption as Elia and Livesey
[37] for their formulas, which remain in keeping and coincide with traditional
indirect calorimetry calculation as introduced by Lusk [37].
The somewhat arbitrary looking choice of definitions Eqs. (17) and (18) can be
justified with our experience that increasing insulin resistance would lead to more
sugar burning and less fat burning. Further it allows for the calculated burning
fraction χk in Eq. (18) to be used as an input variable to calculate the nonprotein
respiratory quotient Rnpk as in Eq. (19). The result of this choice is also that an
increasing (or decreasing) burning fraction χk would translate into a decreasing (or
increasing) nonprotein respiratory quotient Rnpk as demonstrated in Figure 2a and b
and 3a and b.
We calculate the total energy expenditure as in Eq. (20):
TEEk ¼ PAEk þ BMRk: (20)
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